annual CFI:
-$560.00K-$98.62M(-100.57%)Summary
- As of today (June 2, 2025), FOLD annual cash flow from investing activities is -$560.00 thousand, with the most recent change of -$98.62 million (-100.57%) on December 31, 2024.
- During the last 3 years, FOLD annual CFI has fallen by -$79.32 million (-100.71%).
- FOLD annual CFI is now -100.57% below its all-time high of $98.06 million, reached on December 31, 2023.
Performance
FOLD Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$32.86M-$12.47M(-61.15%)Summary
- As of today (June 2, 2025), FOLD quarterly cash flow from investing activities is -$32.86 million, with the most recent change of -$12.47 million (-61.15%) on March 31, 2025.
- Over the past year, FOLD quarterly CFI has dropped by -$40.40 million (-536.00%).
- FOLD quarterly CFI is now -128.71% below its all-time high of $114.48 million, reached on September 30, 2018.
Performance
FOLD quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$40.96M-$40.40M(-7213.93%)Summary
- As of today (June 2, 2025), FOLD TTM cash flow from investing activities is -$40.96 million, with the most recent change of -$40.40 million (-7213.93%) on March 31, 2025.
- Over the past year, FOLD TTM CFI has dropped by -$110.30 million (-159.06%).
- FOLD TTM CFI is now -121.18% below its all-time high of $193.41 million, reached on June 30, 2020.
Performance
FOLD TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
FOLD Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.6% | -536.0% | -159.1% |
| 3 y3 years | -100.7% | -156.4% | -181.3% |
| 5 y5 years | -100.6% | -135.2% | -137.8% |
FOLD Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.6% | at low | -144.1% | +50.7% | -141.8% | at low |
| 5 y | 5-year | -100.6% | +95.9% | -135.2% | +78.7% | -121.2% | +36.6% |
| alltime | all time | -100.6% | +99.7% | -128.7% | +87.5% | -121.2% | +86.8% |
FOLD Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$32.86M(+61.1%) | -$40.96M(+7213.9%) |
| Dec 2024 | -$560.00K(-100.6%) | -$20.39M(-159.5%) | -$560.00K(-86.4%) |
| Sep 2024 | - | $34.27M(-255.9%) | -$4.13M(+56.7%) |
| Jun 2024 | - | -$21.98M(-391.6%) | -$2.63M(-103.8%) |
| Mar 2024 | - | $7.54M(-131.5%) | $69.35M(-29.3%) |
| Dec 2023 | $98.06M(+6.2%) | -$23.96M(-167.0%) | $98.06M(+77.3%) |
| Sep 2023 | - | $35.77M(-28.5%) | $55.32M(-41.2%) |
| Jun 2023 | - | $50.00M(+37.9%) | $94.07M(+33.7%) |
| Mar 2023 | - | $36.26M(-154.4%) | $70.36M(-23.8%) |
| Dec 2022 | $92.32M(+17.2%) | -$66.70M(-189.5%) | $92.32M(+1.5%) |
| Sep 2022 | - | $74.52M(+183.4%) | $90.93M(+78.3%) |
| Jun 2022 | - | $26.29M(-54.8%) | $50.99M(+1.1%) |
| Mar 2022 | - | $58.21M(-185.5%) | $50.41M(-36.0%) |
| Dec 2021 | $78.76M(-680.0%) | -$68.09M(-296.9%) | $78.76M(-36.5%) |
| Sep 2021 | - | $34.57M(+34.5%) | $124.07M(-292.2%) |
| Jun 2021 | - | $25.71M(-70.3%) | -$64.56M(+218.7%) |
| Mar 2021 | - | $86.56M(-480.1%) | -$20.26M(+49.2%) |
| Dec 2020 | -$13.58M(-114.3%) | -$22.78M(-85.2%) | -$13.58M(-137.6%) |
| Sep 2020 | - | -$154.06M(-320.0%) | $36.16M(-81.3%) |
| Jun 2020 | - | $70.01M(-24.9%) | $193.41M(+78.5%) |
| Mar 2020 | - | $93.25M(+245.8%) | $108.33M(+13.9%) |
| Dec 2019 | $95.15M(-178.5%) | $26.96M(+744.4%) | $95.15M(+2068.0%) |
| Sep 2019 | - | $3.19M(-121.2%) | $4.39M(-96.2%) |
| Jun 2019 | - | -$15.07M(-118.8%) | $115.67M(-18.2%) |
| Mar 2019 | - | $80.06M(-225.5%) | $141.47M(-216.7%) |
| Dec 2018 | -$121.20M(-29.2%) | -$63.80M(-155.7%) | -$121.20M(+1966.5%) |
| Sep 2018 | - | $114.48M(+967.2%) | -$5.87M(-98.0%) |
| Jun 2018 | - | $10.73M(-105.9%) | -$294.25M(+12.6%) |
| Mar 2018 | - | -$182.60M(-454.3%) | -$261.43M(+52.7%) |
| Dec 2017 | -$171.24M(+3697.8%) | $51.53M(-129.6%) | -$171.24M(-8.6%) |
| Sep 2017 | - | -$173.91M(-499.4%) | -$187.43M(+334.5%) |
| Jun 2017 | - | $43.55M(-147.1%) | -$43.13M(-55.3%) |
| Mar 2017 | - | -$92.41M(-361.5%) | -$96.48M(+2039.7%) |
| Dec 2016 | -$4.51M(-96.9%) | $35.34M(-219.3%) | -$4.51M(-109.9%) |
| Sep 2016 | - | -$29.61M(+202.3%) | $45.55M(-124.4%) |
| Jun 2016 | - | -$9.80M(+2116.5%) | -$186.90M(+11.6%) |
| Mar 2016 | - | -$442.00K(-100.5%) | -$167.45M(+15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | -$145.34M(+35.7%) | $85.41M(-132.6%) | -$145.34M(-53.2%) |
| Sep 2015 | - | -$262.07M(-2814.3%) | -$310.48M(+298.6%) |
| Jun 2015 | - | $9.65M(-55.4%) | -$77.89M(-2.2%) |
| Mar 2015 | - | $21.66M(-127.2%) | -$79.61M(-25.7%) |
| Dec 2014 | -$107.08M(-510.5%) | -$79.73M(+170.5%) | -$107.08M(+203.3%) |
| Sep 2014 | - | -$29.48M(-471.5%) | -$35.31M(-346.0%) |
| Jun 2014 | - | $7.93M(-236.8%) | $14.35M(+6.2%) |
| Mar 2014 | - | -$5.80M(-27.2%) | $13.52M(-48.2%) |
| Dec 2013 | $26.08M(-166.1%) | -$7.97M(-139.5%) | $26.08M(-48.5%) |
| Sep 2013 | - | $20.18M(+184.3%) | $50.66M(+232.4%) |
| Jun 2013 | - | $7.10M(+5.0%) | $15.24M(-36.6%) |
| Mar 2013 | - | $6.76M(-59.3%) | $24.02M(-160.9%) |
| Dec 2012 | -$39.43M(-184.9%) | $16.61M(-209.0%) | -$39.43M(-2.3%) |
| Sep 2012 | - | -$15.24M(-195.9%) | -$40.35M(+172.6%) |
| Jun 2012 | - | $15.88M(-128.0%) | -$14.80M(-32.6%) |
| Mar 2012 | - | -$56.69M(-461.3%) | -$21.95M(-147.3%) |
| Dec 2011 | $46.45M(-338.9%) | $15.69M(+52.2%) | $46.45M(-491.8%) |
| Sep 2011 | - | $10.31M(+18.1%) | -$11.86M(-10.6%) |
| Jun 2011 | - | $8.73M(-25.5%) | -$13.26M(-28.8%) |
| Mar 2011 | - | $11.72M(-127.5%) | -$18.63M(-4.2%) |
| Dec 2010 | -$19.44M(-161.0%) | -$42.62M(-578.3%) | -$19.44M(-159.0%) |
| Sep 2010 | - | $8.91M(+165.0%) | $32.95M(-16.8%) |
| Jun 2010 | - | $3.36M(-69.2%) | $39.58M(+8.5%) |
| Mar 2010 | - | $10.90M(+11.6%) | $36.49M(+14.5%) |
| Dec 2009 | $31.87M(+46.5%) | $9.77M(-37.1%) | $31.87M(-29.0%) |
| Sep 2009 | - | $15.54M(+5614.7%) | $44.91M(+0.4%) |
| Jun 2009 | - | $272.00K(-95.7%) | $44.74M(-4.2%) |
| Mar 2009 | - | $6.28M(-72.5%) | $46.68M(+114.7%) |
| Dec 2008 | $21.75M(-129.0%) | $22.81M(+48.3%) | $21.75M(-214.9%) |
| Sep 2008 | - | $15.38M(+596.0%) | -$18.93M(-45.2%) |
| Jun 2008 | - | $2.21M(-111.8%) | -$34.52M(-60.9%) |
| Mar 2008 | - | -$18.66M(+4.4%) | -$88.22M(+17.6%) |
| Dec 2007 | -$75.04M(+182.1%) | -$17.87M(+8615.1%) | -$75.04M(+31.2%) |
| Sep 2007 | - | -$205.00K(-99.6%) | -$57.18M(+0.4%) |
| Jun 2007 | - | -$51.49M(+839.0%) | -$56.97M(+939.0%) |
| Mar 2007 | - | -$5.48M | -$5.48M |
| Dec 2006 | -$26.60M(+57.1%) | - | - |
| Dec 2005 | -$16.94M | - | - |
FAQ
- What is Amicus Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Amicus Therapeutics?
- What is Amicus Therapeutics annual CFI year-on-year change?
- What is Amicus Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly CFI year-on-year change?
- What is Amicus Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Amicus Therapeutics?
- What is Amicus Therapeutics TTM CFI year-on-year change?
What is Amicus Therapeutics annual cash flow from investing activities?
The current annual CFI of FOLD is -$560.00K
What is the all time high annual CFI for Amicus Therapeutics?
Amicus Therapeutics all-time high annual cash flow from investing activities is $98.06M
What is Amicus Therapeutics annual CFI year-on-year change?
Over the past year, FOLD annual cash flow from investing activities has changed by -$98.62M (-100.57%)
What is Amicus Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of FOLD is -$32.86M
What is the all time high quarterly CFI for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly cash flow from investing activities is $114.48M
What is Amicus Therapeutics quarterly CFI year-on-year change?
Over the past year, FOLD quarterly cash flow from investing activities has changed by -$40.40M (-536.00%)
What is Amicus Therapeutics TTM cash flow from investing activities?
The current TTM CFI of FOLD is -$40.96M
What is the all time high TTM CFI for Amicus Therapeutics?
Amicus Therapeutics all-time high TTM cash flow from investing activities is $193.41M
What is Amicus Therapeutics TTM CFI year-on-year change?
Over the past year, FOLD TTM cash flow from investing activities has changed by -$110.30M (-159.06%)